\-\ Texto\\:\\ \ \(0\)\
\-\ patient\\ had\\ elevated\\ prolactin\\ levels\\ \\(22\\.5\\ ng\\/ml\\;\\ normal\\ 3\\-18\\.6\\)\\,\\ as\\ well\\ as\\ a\\ slightly\\ elevated\\ estradiol\\ level\\ \\(15\\ pg\\/ml\\)\\.\\ an\\ lrf\\ stimulation\\ test\\ with\\ leuprolide\\ acetate\\ \\(synthetic\\ gonadotropin\\-releasing\\ hormone\\)\\ was\\ ordered\\ to\\ rule\\ out\\ precocious\\ puberty\\,\\ and\\ an\\ mri\\ was\\ ordered\\ to\\ rule\\ out\\ pituitary\\ adenoma\\.\\ a\\ neurology\\/oncology\\ clinic\\ was\\ consulted\\,\\ and\\ at\\ the\\ time\\ the\\ prolactin\\ and\\ estradiol\\ levels\\ had\\ returned\\ to\\ normal\\.\\ however\\,\\ the\\ alpha\\ fetal\\ protein\\ levels\\ were\\ mildly\\ elevated\\ \\(11\\.5\\ ng\\/ml\\;\\ normal\\ 0\\-8\\.5\\ ng\\/ml\\)\\.\ \(0\)\
\-\ normal\\ lrf\\ stimulation\\ labs\\ ruled\\ out\\ precocious\\ puberty\\.\\ csf\\ studies\\ ruled\\ out\\ a\\ germ\\ cell\\ tumor\\ for\\ the\\ intrasellar\\ cyst\\.\\ \\ no\\ calcifications\\,\\ which\\ is\\ common\\ in\\ craniopharyngioma\\,\\ and\\ the\\ absence\\ of\\ a\\ suprasellar\\ lesion\\ rule\\-out\\ craniopharyngioma\\.\\ \\ no\\ treatment\\ is\\ needed\\ if\\ there\\ is\\ no\\ adenoma\\.\\ \\ an\\ mri\\ every\\ year\\ is\\ required\\ to\\ ensure\\ no\\ significant\\ growth\\ has\\ occurred\\.\ \(0\)\
\-\ the\\ first\\ mri\\ showed\\ a\\ pituitary\\ mass\\ of\\ 7\\.5\\ x\\ 4\\.8\\ x\\ 4\\.3\\ mm\\ in\\ height\\,\\ transverse\\,\\ and\\ ap\\ views\\,\\ respectively\\.\\ by\\ age\\ 6\\,\\ the\\ adenoma\\ has\\ grown\\ to\\ 8\\ x\\ 12\\ x\\ 6\\,\\ but\\ has\\ remained\\ stable\\ since\\.\\ imaging\\ shows\\ no\\ anterior\\ or\\ posterior\\ flattening\\ of\\ the\\ pituitary\\ gland\\.\ \(0\)\
\-\ intrasellar\\ cyst\\ with\\ spurious\\ hyperprolactinemia\ \(0\)\
\-\ \\â\\€\\¢\\ pituitary\\ microadenoma\\ \\(intrasellar\\ pituitary\\ cyst\\)\ \(0\)\
\-\ \\â\\€\\¢\\ rathke\\â\\€\\™s\\ cleft\\ cyst\\ remnant\ \(0\)\
\-\ \\â\\€\\¢\\ precoccious\\ puberty\ \(0\)\
\-\ \\â\\€\\¢\\ craniopharyngioma\ \(0\)\
\-\ 1\\ yr\\ old\\ girl\\ presented\\ with\\ premature\\ thelarche\\ and\\ hypertrichosis\\ on\\ legs\\ during\\ the\\ 1st\\ year\\ wellness\\ checkup\\.\ \(1\)\
\-\ http\\:\\/\\/en\\.wikipedia\\.org\\/wiki\\/thelarche\ \(0\)\
\-\ http\\:\\/\\/en\\.wikipedia\\.org\\/wiki\\/hirsutism\ \(0\)\
\-\ the\\ initial\\ concern\\ in\\ this\\ young\\ child\\ was\\ hyper\\-prolactinemia\\ from\\ a\\ suprasellar\\ mass\\ causing\\ the\\ \\"stalk\\ effect\\"\\.\\ \\ http\\:\\/\\/www\\.ncbi\\.nlm\\.nih\\.gov\\/pmc\\/articles\\/pmc2668659\\/\ \(0\)\
\-\ however\\,\\ the\\ imaging\\ did\\ not\\ show\\ a\\ suprasellar\\ mass\\,\\ and\\ the\\ prolactin\\ elevation\\ was\\ minimal\\.\\ \\ prolactin\\ levels\\ due\\ to\\ the\\ stalk\\ effect\\ are\\ usually\\ lower\\ than\\ produced\\ by\\ a\\ prolactinoma\\.\\ however\\,\\ the\\ values\\ from\\ the\\ stalk\\ effect\\ will\\ still\\ be\\ significantly\\ higher\\ than\\ just\\ the\\ slightly\\ elevated\\ prolactin\\ levels\\ this\\ patient\\ showed\\ \\(anywhere\\ from\ \(0\)\
\-\ 100ng\\/ml\\ to\\ under\\ 250ng\\/ml\\ verses\\ this\\ patient\\'s\\ 23ng\\/ml\\)\\.\\ \ \(1\)\
\-\ after\\ discussing\\ this\\ case\\ with\\ a\\ pediatric\\ endocrinologist\\,\\ his\\ top\\ theory\\ was\\ the\\ stress\\ caused\\ to\\ the\\ patient\\.\\ it\\ could\\ be\\ due\\ to\\ the\\ child\\&\\#39\\;s\\ environment\\ at\\ home\\,\\ or\\ the\\ fact\\ the\\ she\ \(0\)\
\-\ just\\ had\\ about\\ 10\\ immunization\\ shots\\ \\(1\\ year\\ check\\-ups\\ are\\ the\\ worst\\)\\.\ \(1\)\
\-\ lastly\\,\\ regarding\\ the\\ ddx\\.\\ i\\ was\\ looking\\ into\\ distinguishing\\ the\\ cysts\\ from\\ the\\ adenoma\\.\\ one\\ thought\\ i\\ had\\ was\\ that\\ the\\ growth\\ of\\ the\\ cyst\\ would\\ be\\ slower\\ than\\ the\\ adenoma\\ presented\\.\\ \ \(0\)\
\-\ followup\\ of\\ the\\ child\\,\\ for\\ early\\ detection\\ of\\ any\\ visual\\ disturbance\\,\\ will\\ prevent\\ loss\\ of\\ sight\\ in\\ the\\ event\\ that\\ the\\ lesion\\ grows\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ prolactin\\:\\ 0\\.06348719566386994\ \(0\)\
\-\ pituitary\\:\\ 0\\.04452098680679046\ \(0\)\
\-\ intrasellar\\:\\ 0\\.041278339999773046\ \(0\)\
\-\ puberty\\:\\ 0\\.038092317398321966\ \(0\)\
\-\ adenoma\\:\\ 0\\.03709453588155938\ \(0\)\
\-\ levels\\:\\ 0\\.03666581489887696\ \(0\)\
\-\ lrf\\:\\ 0\\.036654962261814965\ \(0\)\
\-\ ng\\/ml\\:\\ 0\\.03542634641187536\ \(0\)\
\-\ stalk\\:\\ 0\\.035160901831300745\ \(0\)\
\-\ estradiol\\:\\ 0\\.03089074454406074\ \(0\)\
\-\ suprasellar\\:\\ 0\\.029043463662828437\ \(0\)\
\-\ craniopharyngioma\\:\\ 0\\.028222821098657636\ \(0\)\
\-\ precocious\\:\\ 0\\.027518893333182033\ \(0\)\
\-\ elevated\\:\\ 0\\.02411073897180094\ \(0\)\
\-\ cyst\\:\\ 0\\.02387080182979317\ \(0\)\
\-\ out\\:\\ 0\\.023484855524810947\ \(0\)\
\-\ x\\:\\ 0\\.02344337908812871\ \(0\)\
\-\ child\\:\\ 0\\.023328552653218326\ \(0\)\
\-\ stimulation\\:\\ 0\\.02211646928274436\ \(0\)\
\-\ http\\:\\ 0\\.02018163366723665\ \(0\)\
\-\ ruled\\:\\ 0\\.01977162334062403\ \(0\)\
\-\ effect\\:\\ 0\\.018870425694818577\ \(0\)\
\-\ 22\\.5\\:\\ 0\\.018327481130907482\ \(0\)\
\-\ 3\\-18\\.6\\:\\ 0\\.018327481130907482\ \(0\)\
\-\ gonadotropin\\-releasing\\:\\ 0\\.018327481130907482\ \(0\)\
\-\ neurology\\/oncology\\:\\ 0\\.018327481130907482\ \(0\)\
\-\ 0\\-8\\.5\\:\\ 0\\.018327481130907482\ \(0\)\
\-\ spurious\\:\\ 0\\.018327481130907482\ \(0\)\
\-\ precoccious\\:\\ 0\\.018327481130907482\ \(0\)\
\-\ thelarche\\:\\ 0\\.018327481130907482\ \(0\)\
\-\ hypertrichosis\\:\\ 0\\.018327481130907482\ \(0\)\
\-\ \\/\\/en\\.wikipedia\\.org\\/wiki\\/thelarche\\:\\ 0\\.018327481130907482\ \(0\)\
\-\ \\/\\/en\\.wikipedia\\.org\\/wiki\\/hirsutism\\:\\ 0\\.018327481130907482\ \(0\)\
\-\ hyper\\-prolactinemia\\:\\ 0\\.018327481130907482\ \(0\)\
\-\ \\/\\/www\\.ncbi\\.nlm\\.nih\\.gov\\/pmc\\/articles\\/pmc2668659\\/\\:\\ 0\\.018327481130907482\ \(0\)\
\-\ 100ng\\/ml\\:\\ 0\\.018327481130907482\ \(0\)\
\-\ 250ng\\/ml\\:\\ 0\\.018327481130907482\ \(0\)\
\-\ 23ng\\/ml\\:\\ 0\\.018327481130907482\ \(0\)\
\-\ check\\-ups\\:\\ 0\\.018327481130907482\ \(0\)\
\-\ leuprolide\\:\\ 0\\.016886426701468928\ \(0\)\
\-\ wellness\\:\\ 0\\.016886426701468928\ \(0\)\
\-\ shots\\:\\ 0\\.016886426701468928\ \(0\)\
\-\ ordered\\:\\ 0\\.01671404523230668\ \(0\)\
\-\ was\\:\\ 0\\.016437048186506226\ \(0\)\
\-\ checkup\\:\\ 0\\.01604346389874925\ \(0\)\
\-\ verses\\:\\ 0\\.01604346389874925\ \(0\)\
\-\ growth\\:\\ 0\\.015449696449656132\ \(0\)\
\-\ acetate\\:\\ 0\\.01544537227203037\ \(0\)\
\-\ prolactinoma\\:\\ 0\\.01544537227203037\ \(0\)\
\-\ endocrinologist\\:\\ 0\\.01544537227203037\ \(0\)\
\-\ sight\\:\\ 0\\.01544537227203037\ \(0\)\
\-\ had\\:\\ 0\\.01533347043027616\ \(0\)\
\-\ hyperprolactinemia\\:\\ 0\\.01498145636493222\ \(0\)\
\-\ discussing\\:\\ 0\\.01498145636493222\ \(0\)\
\-\ immunization\\:\\ 0\\.01498145636493222\ \(0\)\
\-\ however\\:\\ 0\\.014840133402892332\ \(0\)\
\-\ rule\\:\\ 0\\.014837814352623753\ \(0\)\
\-\ just\\:\\ 0\\.014837814352623753\ \(0\)\
\-\ i\\:\\ 0\\.014687379190139335\ \(0\)\
\-\ synthetic\\:\\ 0\\.014602409469310693\ \(0\)\
\-\ slightly\\:\\ 0\\.014362687144520055\ \(0\)\
\-\ rule\\-out\\:\\ 0\\.01428192988547024\ \(0\)\
\-\ slower\\:\\ 0\\.01428192988547024\ \(0\)\
\-\ 11\\.5\\:\\ 0\\.014004317842591815\ \(0\)\
\-\ than\\:\\ 0\\.013964961673086949\ \(0\)\
\-\ microadenoma\\:\\ 0\\.013759446666591017\ \(0\)\
\-\ environment\\:\\ 0\\.013759446666591017\ \(0\)\
\-\ 7\\.5\\:\\ 0\\.013540401935493664\ \(0\)\
\-\ lastly\\:\\ 0\\.013161355039872136\ \(0\)\
\-\ grows\\:\\ 0\\.013161355039872136\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.013031304379175783\ \(0\)\
\-\ pg\\/ml\\:\\ 0\\.0129949460842099\ \(0\)\
\-\ 4\\.8\\:\\ 0\\.0129949460842099\ \(0\)\
\-\ grown\\:\\ 0\\.0129949460842099\ \(0\)\
\-\ remnant\\:\\ 0\\.0129949460842099\ \(0\)\
\-\ theory\\:\\ 0\\.0129949460842099\ \(0\)\
\-\ disturbance\\:\\ 0\\.012697439132773988\ \(0\)\
\-\ \\;\\:\\ 0\\.012632564584943412\ \(0\)\
\-\ distinguishing\\:\\ 0\\.012437224698358175\ \(0\)\
\-\ mri\\:\\ 0\\.012244963752066237\ \(0\)\
\-\ alpha\\:\\ 0\\.011901197444091856\ \(0\)\
\-\ anywhere\\:\\ 0\\.011808782137291786\ \(0\)\
\-\ showed\\:\\ 0\\.011649909637936369\ \(0\)\
\-\ 4\\.3\\:\\ 0\\.01163543159895696\ \(0\)\
\-\ yr\\:\\ 0\\.01163543159895696\ \(0\)\
\-\ worst\\:\\ 0\\.01163543159895696\ \(0\)\
\-\ looking\\:\\ 0\\.011256384703335431\ \(0\)\
\-\ normal\\:\\ 0\\.011140228312674437\ \(0\)\
\-\ will\\:\\ 0\\.011116345190765663\ \(0\)\
\-\ rathke\\:\\ 0\\.01099617026891962\ \(0\)\
\-\ consulted\\:\\ 0\\.01082037528341429\ \(0\)\
\-\ \\,\\:\\ 0\\.01069332899132736\ \(0\)\
\-\ 6\\:\\ 0\\.01061172624272297\ \(0\)\
\-\ from\\:\\ 0\\.010531689922280353\ \(0\)\
\-\ \\(\\:\\ 0\\.010512540714567618\ \(0\)\
\-\ 1st\\:\\ 0\\.0104601430146533\ \(0\)\
\-\ regarding\\:\\ 0\\.010413421900615756\ \(0\)\
\-\ \\)\\:\\ 0\\.010384124417449347\ \(0\)\
\-\ ensure\\:\\ 0\\.010323016262487402\ \(0\)\
\-\ detection\\:\\ 0\\.010323016262487402\ \(0\)\
\-\ respectively\\:\\ 0\\.010236378640032998\ \(0\)\
\-\ s\\:\\ 0\\.010190302150164603\ \(0\)\
\-\ hormone\\:\\ 0\\.010073235988387478\ \(0\)\
\-\ produced\\:\\ 0\\.010034375004994229\ \(0\)\
\-\ has\\:\\ 0\\.010008523724496536\ \(0\)\
\-\ event\\:\\ 0\\.009815330273896878\ \(0\)\
\-\ presented\\:\\ 0\\.00968547873190191\ \(0\)\
\-\ remained\\:\\ 0\\.009681154554276147\ \(0\)\
\-\ flattening\\:\\ 0\\.009681154554276147\ \(0\)\
\-\ premature\\:\\ 0\\.009681154554276147\ \(0\)\
\-\ legs\\:\\ 0\\.009617180211933623\ \(0\)\
\-\ top\\:\\ 0\\.009524764905133553\ \(0\)\
\-\ due\\:\\ 0\\.009481401883379792\ \(0\)\
\-\ every\\:\\ 0\\.00943628337827535\ \(0\)\
\-\ occurred\\:\\ 0\\.009407607032885878\ \(0\)\
\-\ ddx\\:\\ 0\\.009379320853975734\ \(0\)\
\-\ height\\:\\ 0\\.00935141436679873\ \(0\)\
\-\ fact\\:\\ 0\\.00935141436679873\ \(0\)\
\-\ the\\:\\ 0\\.009197457610220427\ \(0\)\
\-\ germ\\:\\ 0\\.009191412202274553\ \(0\)\
\-\ protein\\:\\ 0\\.009115803794434895\ \(0\)\
\-\ returned\\:\\ 0\\.009091199932382915\ \(0\)\
\-\ significantly\\:\\ 0\\.009091199932382915\ \(0\)\
\-\ fetal\\:\\ 0\\.00904284886759234\ \(0\)\
\-\ no\\:\\ 0\\.008944325890891914\ \(0\)\
\-\ values\\:\\ 0\\.008881961833048846\ \(0\)\
\-\ concern\\:\\ 0\\.00883819175155647\ \(0\)\
\-\ prevent\\:\\ 0\\.008816647495765313\ \(0\)\
\-\ elevation\\:\\ 0\\.008774217409213948\ \(0\)\
\-\ higher\\:\\ 0\\.008712153036761386\ \(0\)\
\-\ cleft\\:\\ 0\\.008671782795894234\ \(0\)\
\-\ pediatric\\:\\ 0\\.008555172678116594\ \(0\)\
\-\ followup\\:\\ 0\\.008480914710128904\ \(0\)\
\-\ still\\:\\ 0\\.008462757371316524\ \(0\)\
\-\ 1\\:\\ 0\\.008454579492555955\ \(0\)\
\-\ home\\:\\ 0\\.008444757240873459\ \(0\)\
\-\ imaging\\:\\ 0\\.008324631286717683\ \(0\)\
\-\ 39\\:\\ 0\\.008256406107085047\ \(0\)\
\-\ be\\:\\ 0\\.00821885690235299\ \(0\)\
\-\ thought\\:\\ 0\\.008176125782495068\ \(0\)\
\-\ visual\\:\\ 0\\.008053796260617868\ \(0\)\
\-\ this\\:\\ 0\\.007992825058745389\ \(0\)\
\-\ to\\:\\ 0\\.007990879367956085\ \(0\)\
\-\ clinic\\:\\ 0\\.007938266424537179\ \(0\)\
\-\ stress\\:\\ 0\\.0077892187562292456\ \(0\)\
\-\ under\\:\\ 0\\.007763230891854544\ \(0\)\
\-\ needed\\:\\ 0\\.007737563873512965\ \(0\)\
\-\ young\\:\\ 0\\.007737563873512965\ \(0\)\
\-\ causing\\:\\ 0\\.007674749364996339\ \(0\)\
\-\ test\\:\\ 0\\.007589880353519718\ \(0\)\
\-\ mildly\\:\\ 0\\.007566255075660435\ \(0\)\
\-\ gland\\:\\ 0\\.007566255075660435\ \(0\)\
\-\ caused\\:\\ 0\\.007451995440981105\ \(0\)\
\-\ a\\:\\ 0\\.0074207863126141615\ \(0\)\
\-\ csf\\:\\ 0\\.007418907176311876\ \(0\)\
\-\ mass\\:\\ 0\\.007412438712770673\ \(0\)\
\-\ absence\\:\\ 0\\.00738633728703038\ \(0\)\
\-\ an\\:\\ 0\\.007370051128594989\ \(0\)\
\-\ views\\:\\ 0\\.007322689395513527\ \(0\)\
\-\ stable\\:\\ 0\\.007322689395513527\ \(0\)\
\-\ 12\\:\\ 0\\.007271098607322832\ \(0\)\
\-\ lesion\\:\\ 0\\.007237235866945758\ \(0\)\
\-\ transverse\\:\\ 0\\.007123589800727645\ \(0\)\
\-\ patient\\:\\ 0\\.0071234256209263035\ \(0\)\
\-\ 15\\:\\ 0\\.00708595977652054\ \(0\)\
\-\ \\:\\:\\ 0\\.007049531076864855\ \(0\)\
\-\ minimal\\:\\ 0\\.006994760853224112\ \(0\)\
\-\ \\#\\:\\ 0\\.006968163448941556\ \(0\)\
\-\ cysts\\:\\ 0\\.006959372729379141\ \(0\)\
\-\ about\\:\\ 0\\.006848352403543144\ \(0\)\
\-\ 8\\:\\ 0\\.006642656046256442\ \(0\)\
\-\ studies\\:\\ 0\\.006635137043199917\ \(0\)\
\-\ calcifications\\:\\ 0\\.006605330051211544\ \(0\)\
\-\ could\\:\\ 0\\.006554174519398237\ \(0\)\
\-\ mm\\:\\ 0\\.006532630263607081\ \(0\)\
\-\ since\\:\\ 0\\.006525498174008767\ \(0\)\
\-\ ap\\:\\ 0\\.006497211995098623\ \(0\)\
\-\ early\\:\\ 0\\.006497211995098623\ \(0\)\
\-\ did\\:\\ 0\\.006414591769216058\ \(0\)\
\-\ required\\:\\ 0\\.0063944397334454554\ \(0\)\
\-\ would\\:\\ 0\\.006322176462415987\ \(0\)\
\-\ girl\\:\\ 0\\.006246106925134716\ \(0\)\
\-\ \\&\\:\\ 0\\.006239891667653704\ \(0\)\
\-\ labs\\:\\ 0\\.006178740139158292\ \(0\)\
\-\ that\\:\\ 0\\.006137134006481595\ \(0\)\
\-\ 10\\:\\ 0\\.005988823759556987\ \(0\)\
\-\ year\\:\\ 0\\.005963234527689697\ \(0\)\
\-\ first\\:\\ 0\\.00596150402242381\ \(0\)\
\-\ by\\:\\ 0\\.005916303131995321\ \(0\)\
\-\ initial\\:\\ 0\\.005886865162742844\ \(0\)\
\-\ any\\:\\ 0\\.005594251628008927\ \(0\)\
\-\ show\\:\\ 0\\.005453546641354732\ \(0\)\
\-\ during\\:\\ 0\\.005436609667201264\ \(0\)\
\-\ age\\:\\ 0\\.005407297974104588\ \(0\)\
\-\ usually\\:\\ 0\\.005394861234650227\ \(0\)\
\-\ as\\:\\ 0\\.005374542644050428\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.0053098269015498046\ \(0\)\
\-\ loss\\:\\ 0\\.005156890171452057\ \(0\)\
\-\ level\\:\\ 0\\.0051203514088293805\ \(0\)\
\-\ his\\:\\ 0\\.0051203514088293805\ \(0\)\
\-\ time\\:\\ 0\\.0050178819693125\ \(0\)\
\-\ she\\:\\ 0\\.0049870813751646\ \(0\)\
\-\ shows\\:\\ 0\\.004884352806089146\ \(0\)\
\-\ are\\:\\ 0\\.0048435504055284895\ \(0\)\
\-\ if\\:\\ 0\\.004820672419502361\ \(0\)\
\-\ one\\:\\ 0\\.00481441036031319\ \(0\)\
\-\ at\\:\\ 0\\.004813984003457934\ \(0\)\
\-\ cell\\:\\ 0\\.004798837238215148\ \(0\)\
\-\ significant\\:\\ 0\\.004777229004270735\ \(0\)\
\-\ is\\:\\ 0\\.004676014789062168\ \(0\)\
\-\ common\\:\\ 0\\.004649204182861533\ \(0\)\
\-\ anterior\\:\\ 0\\.004575452856055587\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.004366185109421657\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.00428222349684458\ \(0\)\
\-\ into\\:\\ 0\\.004227289746277977\ \(0\)\
\-\ or\\:\\ 0\\.004164335754526851\ \(0\)\
\-\ tumor\\:\\ 0\\.004141855096903973\ \(0\)\
\-\ posterior\\:\\ 0\\.004094882637635028\ \(0\)\
\-\ were\\:\\ 0\\.004033859327837674\ \(0\)\
\-\ well\\:\\ 0\\.004018879320101146\ \(0\)\
\-\ lower\\:\\ 0\\.003995555237762708\ \(0\)\
\-\ it\\:\\ 0\\.003993447784891926\ \(0\)\
\-\ \\'s\\:\\ 0\\.003916936836521923\ \(0\)\
\-\ case\\:\\ 0\\.003886703602634659\ \(0\)\
\-\ but\\:\\ 0\\.003788988151836877\ \(0\)\
\-\ after\\:\\ 0\\.003675678175902708\ \(0\)\
\-\ treatment\\:\\ 0\\.003595877254887499\ \(0\)\
\-\ in\\:\\ 0\\.0035043428701892303\ \(0\)\
\-\ which\\:\\ 0\\.003316308913186172\ \(0\)\
\-\ for\\:\\ 0\\.003031634713691123\ \(0\)\
\-\ there\\:\\ 0\\.0026438992857899975\ \(0\)\
\-\ and\\:\\ 0\\.0026196736800946554\ \(0\)\
\-\ not\\:\\ 0\\.0025671905857420694\ \(0\)\
\-\ old\\:\\ 0\\.0018189908458674732\ \(0\)\
\-\ \\.\\:\\ 0\\.001697483015049822\ \(0\)\
\-\ of\\:\\ 0\\.0016954815084946342\ \(0\)\
\-\ on\\:\\ 0\\.0015049709196786447\ \(0\)\
\-\ with\\:\\ 0\\.0009730077013712245\ \(0\)\
